NOTCH Receptor Antibodies Targeting Cancer Stem Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic and treatment methods for breast, prostate, colorectal, lung, and other cancers are limited in effectively targeting cancer stem cells, leading to inadequate prognosis and treatment outcomes due to phenotypic diversity and heterogeneity in tumors.
Innovation Solution
Development of antibodies that specifically bind to the non-ligand binding region of the extracellular domain of human NOTCH receptors, inhibiting tumor cell growth and targeting cancer stem cells in these cancers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current diagnostic and treatment methods are used, then treatment can be provided to cancer patients, but the methods are limited in effectively targeting cancer stem cells leading to inadequate prognosis and treatment outcomes
Solution Approach 1:
The invention segments the therapeutic approach by developing separate antibodies targeting different NOTCH receptors (NOTCH1, NOTCH2, NOTCH3, NOTCH4) and their ligands, allowing selective inhibition of specific NOTCH signaling pathways in cancer stem cells while preserving other cellular functions
Solution Approach 2:
The invention uses antibodies as intermediary molecules that bind to NOTCH receptors or ligands, blocking the interaction between ligands and receptors, thereby preventing NOTCH signaling activation in cancer stem cells without directly contacting or damaging the cells
2Reliability
If antibodies binding to non-ligand binding region of NOTCH receptors are used, then tumor cell growth is inhibited and cancer stem cells are targeted, but the complexity of the treatment increases
Solution Approach 1:
The invention creates a universal therapeutic platform using antibodies that can target multiple NOTCH receptors (NOTCH1-4) and their ligands (DLL1-4, JAG1-2), providing multi-functional cancer treatment capability through a single approach that can be applied across different cancer types
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The antibodies effectively inhibit tumor cell growth and show promise in treating breast, colon, pancreatic, prostate, lung, rectal, and colorectal cancers by targeting cancer stem cells, potentially offering a better safety profile and improved treatment outcomes compared to existing chemotherapeutic drugs.
Implementation Method 1
an antibody that specifically binds to a non-ligand binding region of the extracellular domain of a human NOTCH receptor
Implementation Method 2
inhibiting tumor cell growth and targeting cancer stem cells in these cancers
Data Source
AI summary
The present invention relates to compositions and methods for characterizing, diagnosing, and treating cancer. In particular the invention provides the means and methods for the diagnosis, characterization, prognosis and treatment of cancer and specifically targeting cancer stem cells. The present invention provides an antibody that specifically binds to a non-ligand binding region of the extracellular domain of a human NOTCH receptor and inhibits growth of tumor cells. The present invention further provides a method of treating cancer, the method comprising administering a therapeutically effective amount of an antibody that specifically binds to a non-ligand binding region of the extracellular domain of a human NOTCH receptor protein and inhibits growth of tumor cells.